Bachem

💼 Scaling up isn’t just about expanding facilities and upgrading equipment. Growth is built on quality and collaboration; it’s about creating an environment where safety and efficiency take center stage. Discover how leaders in our Switzerland and USA sites are setting new standards in peptide API manufacturing through innovative processes and collaborative efforts. 🔎 Head to our blog to see how leaders Sebastian Hartmann and Upinder Singh are preparing Bachem for the future of peptide manufacturing. https://lnkd.in/g7a_7s7v #Bachem #QualityFirst #Peptides

📢 New Video Alert! Learn how to assess and reduce Nitrosamine Contamination Risks in Peptide APIs. In recent years, drug recalls due to nitrosamine drug substance-related impurities (NDSRIs) have become a significant concern. Hear from our expert how Bachem meets the strictest regulatory requirements, ensuring the highest quality and safety for our peptides. 🎥 Stay informed by watching our latest webinar on demand: https://ow.ly/bB6v50TCVPL #Bachem #Nitrosamine #RegulatoryRequirements #CDMO

📅 Save the Date! 📅 Join the insightful presentation of Alexander Kleinsmann, “A second-generation process for the manufacturing of Liraglutide” at TIDES Europe in Hamburg. In the growing peptide generics market, continued intensification and optimization of manufacturing processes are required for CDMOs to remain competitive on cost, speed, quality of peptide API while satisfying increasing regulatory requirements and sustainability goals. Don’t miss out on this opportunity to gain valuable insights into the future of peptide manufacturing! 💡 #TidesEurope #PeptideGenerics #Liraglutide #Bachem #CDMO #Sustainability

We had a fantastic time participating in the 42nd edition of Europe’s largest student-organized recruitment fair at the SwissTech Convention Center on October 10-11! 🎓 With Bachem’s growth plans, we’re on the lookout for talented graduates and specialists in life sciences fields and more. If you’re ready to take the next step in your career with a leading CDMO, explore our open positions here: www.bachem.com/careers 🚀 Thanks to all who visited us! Let’s innovate together! 💼 #Bachem #Careers #EPFLForum

Great news for the oligo world! 🔊 The oligo-therapeutics market has expanded in size, disease indications and exploratory molecules in recent years. As oligo API portfolios have grown more diverse and complex, CDMOs are challenged to provide a toolbox of established and novel solutions to satisfy customer demand. Daniel Bachmann will present at TIDES Europe 2024 about new trends in oligonucleotide therapeutics. 📅 Join this session on November 13 at 11:50h to learn how we as a CDMO meet Pharma's demand. #Oligo #Therapeutics #Tides #Bachem #CDMO

New drugs undergo a rigorous development process before reaching the market. Throughout this journey, they face numerous regulatory challenges to ensure they are safe, reliable, and timely for patients. 📢 Save the Date to join our webinar on October 30 and learn how Bachem meets the strictest regulatory requirements, ensuring the highest quality and safety for our peptides. 📅 Register here: https://ow.ly/3cMM50TmJVg #Pharma #RA #Bachem #Webinar #RegulatoryAffairs #Challenges

It's a wrap! 🌟 Three exciting and insightful days for Bachem at #CPHImilan have come to a close. Thanks to everybody who visited our booth, for all the interesting discussions and the new connections made! We can't wait to be back at #CPHIworldwide in #Frankfurt next year October 28-30. Did you not have the chance to meet our colleagues in Milan? There are some additional major industry events coming up soon where BACHEM will be present: 🔹 𝐓𝐈𝐃𝐄𝐒 𝐄𝐮𝐫𝐨𝐩𝐞 | 𝐇𝐚𝐦𝐛𝐮𝐫𝐠 | 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟏𝟐-𝟏𝟒 🔹 𝐂𝐏𝐡𝐈 𝐈𝐧𝐝𝐢𝐚 | 𝐆𝐫𝐞𝐚𝐭𝐞𝐫 𝐍𝐨𝐢𝐝𝐚, 𝐃𝐞𝐥𝐡𝐢 | 𝐍𝐨𝐯𝐞𝐦𝐛𝐞𝐫 𝟐𝟔-𝟐𝟖 See you there! 👋🏼 #peptides #oligos #cdmo

CPhI Worldwide in #Milano has opened its doors. Let's meet at our booth 2A26 - we are ready to welcome you! 🤝 #peptides #oligos #cphiworldwide #cphimilan

🌱 Bachem is committed to ensuring a sustainable future by conserving resources, mitigating environmental risks, and reducing the emission of harmful greenhouse gases. One of our key objectives is to halve greenhouse gas emissions per FTE by 2026, with the ultimate goal to be climate neutral by 2030. To meet these targets, we continuously monitor and enhance our social, economic, and environmental performance. Read more about our sustainability efforts in our 2023 annual report: https://ow.ly/Usbs50Tp5Ir #environment #greenchemistry #sustainability #peptides #climateneutral

🙋♂️🙋♀️ We look forward to meeting you in October. 💙 🔵 Meet Christopher McGee, Ph.D., Seema Zaidi & Joseph Fraone at Oligonucleotide Therapeutics Society in Montréal October 6-9 - Booth 4-3 🔵 Meet Henriot Stéphanie at the European Meeting on Molecular Diagnostics in Noordwijk October 9-11 - Booth 23 🔵 Meet Aya I., Naoki Yamamoto & Keiko Nomura at BioJapan in Yokohama October 9-11 - Swiss Pavilion D-64 📆 Not there? Have a look at all the other events where you can meet us: https://lnkd.in/erseqbAJ #peptides #oligos #events #October #meetus